HIV treatment
Real-World Data Show Continued Virologic Suppression With Cabenuva
At CROI 2025, new research has shown high rates of continued virologic suppression with cabotegravir-rilpivirine ...
MARCH 25, 2025
For Advanced HIV, 2-Drug Dovato Regimen as Effective as 3 Drugs
The two-drug regimen of dolutegravir-lamivudine achieves comparable efficacy to three-drug therapy regimens in ...
MARCH 21, 2025
High Rates of PrEP Adherence and Persistence for F/TAF Patients
Patients who are naive to HIV PrEP and prescribed Descovy (Gilead) have a greater number of prescription dispenses, ...
JANUARY 6, 2023
Novel HIV Combination Therapies Could Prevent Viral Escape and Rebound
Computational approaches to selecting combinations of bNAbs based on viral genetics could help prevent viral ...
JULY 20, 2022
FDA Approves Delstrigo and Pifeltro for HIV Treatment
The FDA approved Merck’s two doravirine-based HIV-1 medicines: Delstrigo, a once-daily fixed-dose combination ...
AUGUST 30, 2018
Janssen, ViiV Healthcare Collaborate on HIV Regimen Study
A two-drug combination of cabotegravir and rilpivirine is being studied for HIV.
JANUARY 19, 2016
